Order of the Court (Eighth Chamber) of 14 November 2013.   Glaxosmithkline Biologicals SA and Glaxosmithkline Biologicals; Niederlassung der Smithkline Beecham Pharma GmbH &amp; Co. KG v Comptroller General of Patents; Designs and Trade Marks.   Reference for a preliminary ruling: High Court of Justice (England &amp; Wales); Chancery Division (Patents Court) - United Kingdom.   Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Concepts of ‘active ingredient’ and ‘combination of active ingredients’ - Adjuvant. 